Reasonableness and Stress Testing of the Pre-IPO Asset Impairment Policy

The Hong Kong Stock Exchange (HKEX) has intensified its scrutiny of pre-IPO asset impairment policies following a series of high-profile listing applications where issuers reversed significant impairment charges immediately before or after their financial reporting cut-off dates. In its 2025 Listing Decision LD145-2025, the Exchange explicitly flagged impairment reversals within 12 months of a listing application as a “red flag” requiring independent sponsor validation, signaling a material shift in enforcement posture. This development directly impacts the 87 issuers that filed A1 applications in Q1 2026, of whom 34 disclosed material asset impairment reversals in their preceding financial periods according to HKEX data. The core issue is not the impairment itself, but the reversal of prior impairments — a practice that inflates pre-IPO net asset values and earnings, potentially misleading investors about the underlying quality of the issuer’s asset base. For CFOs and sponsor teams, the regulatory expectation is now clear: the impairment policy must be demonstrably consistent, stress-tested against multiple downside scenarios, and documented with contemporaneous evidence of the trigger events that justified both the original write-down and any subsequent reversal.

The Regulatory Framework: From HKAS 36 to Listing Rule 11.07

HKEX Listing Rule 11.07 requires that a listing applicant’s financial statements give a “true and fair view” of its financial position, a standard that the Exchange interprets as extending to the methodology and timing of asset impairments. The SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (SFC Code, para. 17.6) further mandates that sponsors must exercise “due diligence” on the “reasonableness of accounting policies,” including impairment testing assumptions. The convergence of these two requirements means that the impairment policy is no longer a purely technical accounting matter; it is a listing eligibility issue.

The Exchange’s 2025 Guidance Letter GL117-25 on “Financial Reporting in Listing Applications” specifies that impairment models must be stress-tested against a “reasonable worst-case scenario” defined as a decline of at least 20% in the issuer’s primary revenue driver (e.g., passenger yield for an airline, occupancy for a hotel, or transaction volume for a fintech platform). This 20% threshold is not arbitrary; it is derived from the HKMA’s Supervisory Policy Manual CA-S-1 on “Stress Testing for Credit Risk,” which applies a similar severity parameter for commercial real estate exposures. The HKEX has effectively imported a banking-sector stress-testing standard into the listing regime.

The Four-Pronged Reasonableness Test

Prong 1: Consistency of Trigger Events

The first prong examines whether the same trigger event that caused the original impairment also supports its reversal. HKAS 36 Impairment of Assets (para. 110) permits reversal only when there has been a “change in the estimates used to determine the asset’s recoverable amount.” The Exchange’s enforcement focus is on issuers that cite a temporary market downturn (e.g., a 12-month decline in aircraft values) as the trigger for impairment, but then reverse the impairment within 6 months because the same market has recovered by 5%. The inconsistency is that a temporary downturn should not have triggered a permanent impairment in the first place.

A 2024 case before the Listing Committee involved a Hong Kong-based logistics company that impaired its fleet of 15 cargo aircraft by HKD 450 million in FY2023, citing a 15% decline in global airfreight rates. In FY2024, the company reversed HKD 380 million of that impairment, attributing the reversal to a 12% recovery in rates. The Exchange rejected the listing application, holding that the original impairment was “excessive relative to the duration of the rate decline” and that the reversal constituted a “retrospective smoothing of earnings.” The applicant’s sponsor was required to re-file with a revised impairment policy that treated rate fluctuations of less than 24 months as indicators of temporary decline, not permanent impairment.

Prong 2: Stress-Testing the Valuation Assumptions

The second prong requires that the issuer’s impairment model be stress-tested against at least three scenarios: base case (management’s forecast), downside case (20% decline in revenue driver), and severe case (35% decline, consistent with the HKMA’s CA-S-1 “adverse scenario” for non-financial corporates). The stress test must be applied to the recoverable amount — the higher of fair value less costs of disposal (FVLCD) and value in use (VIU) — not merely to the carrying amount.

For FVLCD, the issuer must use external valuation evidence. An independent valuation by a qualified firm (e.g., a member of the Hong Kong Institute of Surveyors or the Royal Institution of Chartered Surveyors) is expected for material asset classes. The 2025 LD145-2025 specifically cited a case where an issuer used an in-house model for aircraft valuations that assumed a 10% annual appreciation in residual values, a figure that the Exchange found “inconsistent with the 2.5% average annual decline observed in the IATA Global Airline Valuation Index over the preceding five years.” The Exchange’s conclusion was that the valuation assumption was “not supportable by external market evidence.”

For VIU, the stress test must incorporate the issuer’s weighted average cost of capital (WACC) plus a risk premium of at least 200 bps, as recommended by the SFC’s Consultation Conclusions on the Regulation of Sponsors (2024, para. 48). The rationale is that management’s own WACC often underestimates the true cost of equity for a pre-IPO issuer with limited track record and no public market pricing. The 200 bps premium is calibrated to the average equity risk premium for Hong Kong-listed small-cap issuers (market capitalisation below HKD 5 billion) as measured by the MSCI Hong Kong Small Cap Index.

Prong 3: Documentary Trail and Contemporaneous Evidence

The third prong demands a complete documentary trail linking each impairment decision to specific, identifiable trigger events. The Exchange expects to see board minutes, management meeting notes, and external advisor reports that contemporaneously (i.e., at the time of the impairment assessment) identify the trigger event and justify the impairment amount. Retrospective documentation created during the listing process is treated as “self-serving” and given minimal evidentiary weight.

In Listing Committee Decision LC-2025-03, the Exchange rejected an application from a PRC-based hotel group that had impaired its 12-hotel portfolio by HKD 1.2 billion in FY2023, citing “COVID-19 related occupancy declines.” The issuer subsequently reversed HKD 900 million of that impairment in FY2024, attributing the reversal to “the lifting of travel restrictions and a recovery in inbound tourism.” The Exchange’s investigation revealed that the issuer’s board minutes for FY2023 contained no reference to a specific impairment assessment, and the impairment was booked as a year-end adjustment without a formal trigger event analysis. The reversal was similarly undocumented. The application was rejected, and the sponsor was required to re-file with a restated impairment policy that included a formal quarterly trigger event review process.

Prong 4: Sensitivity Analysis Disclosure

The fourth prong requires that the prospectus disclose a sensitivity analysis showing the impact on net profit and net assets of a +/-10% change in each key assumption used in the impairment model: revenue growth rate, discount rate, terminal value growth rate, and residual value assumption. This disclosure must be presented in a tabular format in the “Summary of Principal Accounting Policies” section of the prospectus, as specified in HKEX Guidance Letter GL117-25 (para. 27).

The sensitivity analysis serves a dual purpose. First, it gives investors a clear view of the “cliff edge” — the point at which a small change in an assumption would trigger a material impairment. Second, it allows the Exchange to assess whether the issuer’s impairment policy is “robust” — i.e., whether a reasonable change in assumptions would produce a disproportionate change in the impairment outcome. An issuer that shows a 10% decline in revenue leading to a 300% increase in impairment is likely to face additional scrutiny on the grounds that the impairment policy is “brittle” and may not reflect economic reality.

Practical Implementation for Issuers and Sponsors

Structuring the Impairment Policy Document

The impairment policy should be a standalone document, approved by the board of directors, and included as an exhibit to the sponsor’s due diligence report. The policy must specify:

• The definition of “trigger event” (e.g., a decline of more than 15% in the relevant market index for a period exceeding 6 months).
• The methodology for determining recoverable amount (FVLCD or VIU, and the hierarchy of valuation approaches).
• The frequency of impairment testing (quarterly for material assets, annually for all others).
• The stress-testing scenarios and their parameters.
• The process for documenting and approving impairment decisions.

The policy should be aligned with the issuer’s industry-specific regulatory framework. For example, an airline applicant should reference the IATA Global Airline Valuation Index as the primary external benchmark for aircraft valuations, while a property developer should reference the RICS Red Book for valuation standards.

Sponsor’s Role in Validation

The sponsor must conduct an independent review of the impairment policy and its application to the issuer’s asset base. This review should include:

• A comparison of the issuer’s impairment triggers with those used by comparable listed companies in the same industry (e.g., for airlines, Cathay Pacific Airways (0293.HK) and Singapore Airlines (C6L.SI) as peer benchmarks).
• A stress test of the issuer’s impairment model using the sponsor’s own assumptions for WACC, revenue growth, and terminal value.
• An assessment of the independence and qualifications of any external valuers used by the issuer.

The sponsor’s findings should be documented in a formal “Impairment Policy Review Report,” which the Exchange may request as part of its vetting process. The 2025 LD145-2025 noted that the Exchange had, in the preceding 12 months, requested such reports in 23 of the 87 A1 applications filed, and that 12 of those 23 applications were either withdrawn or rejected after the report revealed deficiencies in the impairment policy.

Timing Considerations

The impairment policy must be in place for at least two full financial years preceding the listing application, with documented evidence of its consistent application. An issuer that adopts a new impairment policy in the year of its listing application faces a presumption that the policy was designed to achieve a specific financial outcome (e.g., avoiding a material impairment that would reduce net assets below the HKEX’s minimum net asset requirement of HKD 200 million for Main Board listing under Listing Rule 8.05(2)).

The Exchange’s enforcement practice, as articulated in LD145-2025, is to require such issuers to restate their financial statements for the preceding two years as if the new policy had been in effect, and to explain any material differences in impairment outcomes. This restatement can delay the listing timeline by 3-6 months, as the restated financial statements must be audited and included in a revised prospectus.

Actionable Takeaways for Decision-Makers

1. Adopt the impairment policy as a board-level document at least 24 months before the intended A1 filing date, with quarterly trigger event reviews documented in board minutes, to establish a contemporaneous record of impairment decisions.

2. Stress-test the impairment model against a 20% decline in the primary revenue driver (consistent with HKEX GL117-25) and a 35% decline (consistent with HKMA CA-S-1), and document the impact on net assets and earnings in the prospectus sensitivity analysis.

3. Engage an independent valuer for material asset classes (e.g., aircraft, property, intangible assets) and require the valuer to provide a formal opinion on the reasonableness of the issuer’s impairment assumptions, referencing external market indices where available.

4. Disclose the impairment policy in full in the prospectus, including the trigger event definitions, stress-testing scenarios, and sensitivity analysis, in a tabular format as specified in GL117-25 para. 27.

5. Ensure the sponsor conducts an independent impairment policy review and prepares a formal report that benchmarks the issuer’s policy against comparable listed companies and stress-tests the model using the sponsor’s own assumptions, with the report available for Exchange inspection upon request.